Cantitate/Preț
Produs

Thyroid Eye Disease

Editat de Raymond S. Douglas, Allison N. McCoy, Shivani Gupta
en Limba Engleză Hardback – 28 noi 2014

Gestionarea bolii oculare tiroidiene (TED) reprezintă una dintre cele mai complexe provocări clinice la intersecția dintre endocrinologie și oftalmologie, necesitând adesea o echilibrare fină între controlul metabolic și intervențiile structurale. Notăm cu interes modul în care Thyroid Eye Disease, sub coordonarea editorilor Raymond S. Douglas, Allison N. McCoy și Shivani Gupta, reușește să condenseze un volum vast de date clinice într-un format riguros, axat pe dovezi. Găsim în această lucrare o resursă esențială pentru diagnosticul diferențial, inclusiv în cazurile atipice de TED eutiroidian, unde evaluarea corectă a autoanticorpilor devine crucială. Structura volumului reflectă o progresie logică a managementului pacientului. Primele capitole fundamentează bazele endocrine și rolul fibrocitelor în patogeneză, trecând ulterior către factori de risc modificabili, precum fumatul și nutriția. Credem că valoarea practică a cărții este amplificată de capitolele dedicate managementului medical în funcție de severitate, de la utilizarea steroizilor până la terapiile biologice de ultimă generație. Spre final, accentul se mută pe soluții chirurgicale, detaliind decompresia orbitală minim invazivă și procedurile de reabilitare estetică. Ca alternativă la Recent Developments in Graves’ Ophthalmopathy pentru rezidenți și practicieni, acest manual oferă avantajul unei organizări axate pe protocoale decizionale și liste de verificare care simplifică parcursul clinic într-o patologie adesea impredictibilă. Față de Surgery in Thyroid Eye Disease, care se concentrează strict pe tehnică, lucrarea de față asigură o viziune holistică, incluzând chiar și tulburările psihologice asociate.

Citește tot Restrânge

Preț: 69496 lei

Preț vechi: 73153 lei
-5%

Puncte Express: 1042

Carte tipărită la comandă

Livrare economică 26 mai-09 iunie
Livrare express 21-25 aprilie pentru 10342 lei


Specificații

ISBN-13: 9781493917457
ISBN-10: 1493917455
Pagini: 168
Ilustrații: X, 157 p. 46 illus., 26 illus. in color.
Dimensiuni: 183 x 260 x 15 mm
Greutate: 0.53 kg
Ediția:2015
Editura: Springer
Locul publicării:New York, NY, United States

Public țintă

Professional/practitioner

De ce să citești această carte

Recomandăm această carte oftalmologilor și endocrinologilor care caută o sinteză clinică actualizată. Cititorul câștigă acces la strategii de tratament bazate pe date, de la utilizarea iodului radioactiv până la chirurgia estetică reparatorie. Este un instrument valoros datorită algoritmilor de decizie și abordării multidisciplinare, fiind ideal atât ca text de studiu, cât și ca referință rapidă în cabinet pentru cazurile de boală Graves cu manifestări oculare.


Despre autor

Raymond S. Douglas este un specialist recunoscut la nivel internațional în oftalmologie și chirurgie oculoplastică, fiind un expert de frunte în tratamentul bolii oculare tiroidiene. Alături de Allison N. McCoy și Shivani Gupta, acesta coordonează o echipă multidisciplinară care integrează cercetarea de laborator cu practica clinică avansată. Contribuțiile editorilor în acest domeniu sunt marcate de o înțelegere profundă a mecanismelor moleculare ale bolii Graves, Douglas fiind implicat activ în dezvoltarea de noi terapii biologice care au redefinit standardele de îngrijire pentru pacienții cu TED.


Descriere scurtă

This book offers ophthalmologists and medical practitioners a concise, data-driven review of the information that is most relevant in guiding the diagnosis and management of thyroid-associated eye diseases (TED). Thyroid-Associated Eye Disease can be read in its entirety to give a perspective of the field, but also considered as a reference as clinical questions arise.   The goal is to deliver data- driven guidance and discreet approaches and suggestions useful for clinical practice and decision making.
Advances in diagnostic evaluation, including autoantibody assessment, are reviewed, and the diagnostic features of euthyroid TED are also discussed. All relevant aspects of treatment are covered, from the use of radioactive iodine, long-term medical therapy, and surgical thyroidectomy through to the treatment of active TED by steroids and novel biologics and the role of minimally invasive surgery. Numerous supporting images are included, and helpful checklists will aid the practitioner in treatment decision making.
 

Cuprins

Chapter 1 Diagnosis and Endocrine Management of Graves’ Disease; Chapter 2 Natural History of Thyroid Eye Disease; Chapter 3 Emerging Role of Fibrocytes in the Pathogenesis of Thyroid Eye Disease;   Chapter 4 Management of Hyperthyroidism and the Effects on Thyroid Eye Disease;   Chapter 5 Smoking and Prevention of Thyroid Eye Disease;  Chapter 6 Nutrition and Supplements in Thyroid Eye Disease; Chapter 7 Pregnancy and Childhood Thyroid Eye Disease;  Chapter 8 Medical Management of Mild and Moderate to Severe Thyroid Eye Disease;  Chapter 9  Management of Severe Thyroid Eye Disease and Use of Biological Agents;  Chapter 10 Strabismus in Thyroid Eye Disease; Chapter 11  Customized Minimally Invasive Orbital Decompression for Thyroid Eye Disease;  Chapter 12 Non-Invasive, Minimally Invasive and Surgical Pearls for Cosmetic Rejuvenation of the Thyroid Eye Disease Patient; Chapter 13 Psychological Disturbances in Thyroid Eye Disease  

Recenzii

From the book reviews:
“The purpose is to help summarize and interpret the most recent studies and data related to thyroid eye disease. This book is useful for ophthalmologists, endocrinologists, general physicians, and residents. … This is an outstanding book that helps summarize important advances in the management of patients with thyroid eye disease. It is well written and extremely useful for those managing these difficult patients.” (Christopher B. Chambers, Doody’s Book Reviews, March, 2015)

Notă biografică

Raymond S. Douglas, MD, PhD, studied at the University of Pennsylvania and subsequently completed his residency in ophthalmology at the Scheie Eye Institute, University of Pennsylvania and his fellowship in orbital facial plastic and reconstructive surgery at the Jules Stein Eye Institute, University of California, Los Angeles. He is currently Associate Professor of Ophthalmology and Visual Sciences and a specialist in eye plastic, orbital, and facial cosmetic Surgery at the University of Michigan, Kellogg Eye Institute. Dr. Douglas’ particular interests include orbital surgery, especially minimally invasive surgery, and decompressions for thyroid-associated eye disease; cosmetic facial surgery; and post-cancer reconstruction, including Mohs surgery.
Allison N. McCoy, MD, PhD, undertook her medical training at Duke University, Durham, North Carolina and also gained a doctorate in Neurobiology from the same university. Between 2008 and 2011 she served an Ophthalmology Residency at the Wilmer Eye Institute, Baltimore, and she is currently a Fellow in Eye Plastic, Orbital, and Facial Cosmetic Surgery. Dr. McCoy has been involved in a number of research projects and has been the recipient of the Neil Miller Research Grant Award, the Michael Boland Research Grant Award, the Mitchell Prize for Resident Research, and a Heed Fellowship. She is the author of 15 peer-reviewed publications.
Shivani Gupta, MD, MPH is an Eye Plastic, Orbital and Facial Cosmetic Surgery Lecturer in the Department of Ophthalmology and Visual Sciences at the University of Michigan. Her special interests include orbital surgery, cosmetic facial surgery including fillers and Botox injections, eyelid and lacrimal disorders, post-cancer reconstruction including Mohs' surgery.

Textul de pe ultima copertă

This book offers ophthalmologists and medical practitioners a concise, data-driven review of the information that is most relevant in guiding the diagnosis and management of thyroid eye disease (TED). Particular attention is devoted to research and clinical trials that have advanced the field in recent years.
Progress in our understanding of the pathogenesis of TED is described, and the heterogeneous natural history of TED is discussed to facilitate preemptive interventions. Advances in diagnostic evaluation, including autoantibody assessment, are reviewed with regard to their clinical utility. The diagnostic features of euthyroid TED are also carefully covered since these patients often represent a diagnostic dilemma.
All relevant aspects of treatment are addressed including the role of radioactive iodine, long-term medical therapy, and surgical thyroidectomy. The impact of these treatment modalities on eye disease are discussed. Management of active TED is reviewed according to the severity of disease and in the light of recent findings and the introduction of novel agents. The discussion encompasses the role of steroids and other agents, the use of novel biologics, the medical and surgical treatment of optic neuropathy, and minimally invasive, customized reconstructive surgery. Numerous supporting images are included, and helpful checklists will aid the practitioner in treatment decision making.

Caracteristici

Numerous images and checklists to guide management Focus on the latest research findings Surgical videos providing step-by-step instructions for the most effective techniques and treatment strategies